- Home
- / COMPASS Pathways
COMPASS Pathways
Stock Price
$6.2
2024-10-29
Market Capitalization
$435.6 M
2024-10-29
COMPASS Pathways Summary
Company Summary
- Overview
- COMPASS Pathways is a biotech company providing patient pathways and therapies for mental healthcare. It develops psilocybin therapy for treatment-resistant depression.
- Type
- Public
- Status
- Active
- Founded
- 2016
- HQ
- Altrincham, GB | view all locations
- Website
- https://compasspathways.com/
- Cybersecurity rating
Table of Contents
Key People
Lars Christian Wilde, Co-Founder
Ekaterina Malievskaia, Co‑Founder
Annalisa Jenkins, Independent Director
Operating MetricsView all
Partners
4
May, 2020
LocationsView all
1 location detected
Altrincham, England HQ
United Kingdom
3rd floor, 1 Ashley Rd
COMPASS Pathways Financials
Summary Financials
- Gross profit (Q1, 2026)
- $484.0K
- Net income (Q1, 2026)
- $91.2M
- Cash (Q1, 2026)
- $466.0M
- EBIT (Q1, 2026)
- $91.0M
- Enterprise value
- $20.1M